Patients at elevated cardiac risk who were treated with beta-blockers on the day of or following noncardiac, nonvascular surgery had significantly lower rates of 30-day mortality and cardiac illness, according to a study in the April 24 issue of JAMA. "The effectiveness and safety of...
The preliminary results of a new study to be presented at a conference in March are causing scientists to ask if beta-blockers, a class of drugs commonly used to treat high blood pressure and heart conditions, can reduce dementia risk. The study found autopsies of elderly men revealed those...
A regional quality improvement effort aimed at increasing the use of preoperative beta-blocker (BB) usage to help prevent postoperative myocardial infarction (POMI) was revealed today at the 64th Vascular Annual Meeting® presented by the Society for Vascular Surgery®. This quality improvement...